My Companies
Notification
Account
Log Out
Login
Brooks Laboratories' board approved the sale of a 16.33% stake in Brooks Steriscience Limited for ₹106.33 crore. Post-transaction, the company will retain a 32.67% stake. Proceeds will fund expansion, capacity enhancement, and general corporate purposes.
Brooks Laboratories Approves 1:1 Demerger Of 96 Percent Business Into Abridge
Brooks Laboratories Secures USD 22.87 Million Floor For Retained Brooks Steriscience Stake